These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14621868)

  • 1. Cyclosporin A has no impact on alterations of the lipid profile after renal transplantation.
    Rosman J; Evequoz D; Landmann J; Thiel G
    Transpl Int; 1992; 5 Suppl 1():S532-5. PubMed ID: 14621868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids.
    Akman B; Uyar M; Afsar B; Sezer S; Ozdemir FN; Haberal M
    Transplant Proc; 2007; 39(1):135-7. PubMed ID: 17275490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some aspects of hemostasis in kidney transplant recipients maintained on cyclosporine, azathioprine, and prednisone in comparison to patients treated with cyclosporine and prednisone.
    Malyszko J; Malyszko JS; Hryszko T; Mysliwiec M
    Transplant Proc; 2003 Dec; 35(8):2940-2. PubMed ID: 14697944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years.
    Thiel G; Bock A; Spöndlin M; Brunner FP; Mihatsch M; Rufli T; Landmann J
    Transplant Proc; 1994 Oct; 26(5):2493-8. PubMed ID: 7940765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal allograft immunosuppression. IV. Comparison of lipid and lipoprotein profiles in blood using double and triple immunosuppressive drug combinations.
    Isoniemi H; Tikkanen MJ; Ahonen J; Häyry P
    Transpl Int; 1991 Sep; 4(3):130-5. PubMed ID: 1958276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid abnormalities in stable liver transplant recipients--effects of cyclosporin, tacrolimus, and steroids.
    Fernández-Miranda C; Guijarro C; de la Calle A; Loinaz C; Gonzalez-Pinto I; Gómez-Izquierdo T; Larumbe S; Moreno E; del Palacio A
    Transpl Int; 1998; 11(2):137-42. PubMed ID: 9561680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.
    Sugioka N; Kokuhu T; Okamoto M; Yoshimura N; Ito Y; Shibata N; Takada K
    J Pharm Pharmacol; 2006 Sep; 58(9):1193-200. PubMed ID: 16945177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline as an adjunct to cyclosporine-based immunosuppression does not improve the outcome of renal transplantation.
    Königsrainer A; Aichberger C; Riedmann B; Steurer W; Ofner D; Margreiter R
    Transplant Proc; 1995 Feb; 27(1):1062-3. PubMed ID: 7878805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine monotherapy versus conventional therapy in the living-related renal transplant: a one center retrospective study.
    Masri MA; Shakuntala V; Dhawan IK; Zahir M; Shanwaz M; Hayes K; Pingle A
    Transplant Proc; 1993 Jun; 25(3):2248-9. PubMed ID: 8516889
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporin A-induced transient rise in plasma alkaline phosphatase in kidney transplant patients.
    Briner VA; Landmann J; Brunner FP; Thiel G
    Transpl Int; 1993 Mar; 6(2):99-107. PubMed ID: 8447931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive protocols at transplantation centers in Turkey.
    Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
    Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of cyclosporin A on the level of big endothelin in patients one year after orthotopic heart transplantation.
    Kocík M; Málek I; Glagolicová A; Pirk J
    Transpl Int; 2004 Feb; 17(2):65-70. PubMed ID: 14634722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion from cyclosporin to azathioprine in renal allograft recipients.
    Otieno LS; Kinuthia DM; McLigeyo SO; Orinda DA; Mwongera FK
    East Afr Med J; 1991 Sep; 68(9):720-6. PubMed ID: 1797535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
    Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
    Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone.
    Casez JP; Lippuner K; Horber FF; Montandon A; Jaeger P
    Nephrol Dial Transplant; 2002 Jul; 17(7):1318-26. PubMed ID: 12105258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation.
    Brown JH; Murphy BG; Douglas AF; Short CD; Bhatnagar D; Mackness MI; Hunt LP; Doherty CC; Durrington PN
    Nephron; 1997; 75(3):277-82. PubMed ID: 9069448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
    Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
    Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal cyclosporine therapy--an Indian experience.
    Raj DS; Somiah S; Mani K
    J Assoc Physicians India; 1996 Jan; 44(1):34-6. PubMed ID: 8773092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abbreviated kinetic profiles to estimate exposure to CyA in renal allograft recipients treated with Sandimmun-Neoral.
    Serafinowicz A; Gaciong Z; Majchrzak J; Baczkowska T; Nowacka E; Gradowska L; Rowiński W; Lao M
    Transplant Proc; 1997; 29(1-2):277-9. PubMed ID: 9122994
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of cytomegalovirus disease in renal transplant patients treated with prednisone, azathioprine and cyclosporine using intensive monitoring and decreased immunosuppression.
    Gómez E; de Oña M; Mélon S; Alvarez R; Laures A; Rodríguez M; Pobes A; Alvarez-Grande J
    Nephron; 1999; 82(3):238-45. PubMed ID: 10395996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.